Back
Manhattan Bridge Capital, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
43
LOAN
Manhattan Bridge Capital, Inc.
Last Price:
$4.67
Seasonality Move:
-3.56%
Sell
45
LYEL
Lyell Immunopharma, Inc.
Last Price:
$31.56
Seasonality Move:
-22.7%
Sell
43
Manhattan Bridge Capital, Inc. (LOAN)
is a Sell
Is Manhattan Bridge Capital, Inc. a Buy, Sell or Hold?
-
The current Manhattan Bridge Capital, Inc. [LOAN] share price is $4.70. The Score for LOAN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
LOAN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Lyell Immunopharma, Inc. (LYEL)
is a Sell
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $31.59. The Score for LYEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
LYEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LOAN Stock Price Chart
What is Manhattan Bridge Capital, Inc.'s stock price today?
-
The Manhattan Bridge Capital, Inc. share price today is $4.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LOAN is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $31.59The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
LOAN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 41.06 | Sell |
| Chaikin Money Flow: | -49002 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.66 - 4.9) | Sell |
| Bollinger Bands (100): | (4.79 - 5.45) | Sell |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.61 | Buy |
| Relative Strength Index (14 RSI): | 54.3 | Buy |
| Chaikin Money Flow: | -97541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.36 - 35.26) | Buy |
| Bollinger Bands (100): | (10.99 - 25.97) | Buy |
LOAN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.87 | Sell |
| 20-day SMA: | 4.81 | Sell |
| 50-day SMA: | 4.85 | Sell |
| 200-day SMA: | 5.23 | Sell |
| 8-day EMA: | 4.83 | Sell |
| 20-day EMA: | 4.82 | Sell |
| 50-day EMA: | 4.81 | Sell |
| 200-day EMA: | 3.31 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.22 | Sell |
| 20-day SMA: | 31.47 | Buy |
| 50-day SMA: | 23.56 | Buy |
| 200-day SMA: | 14.09 | Buy |
| 8-day EMA: | 34.44 | Sell |
| 20-day EMA: | 31.53 | Buy |
| 50-day EMA: | 25.65 | Buy |
| 200-day EMA: | 18.32 | Buy |
Manhattan Bridge Capital, Inc. Earnings Growth & LOAN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.96 per share, and a decrease next year of $0.00 per share.
Manhattan Bridge Capital, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||